This randomized trial explores creating multi-metalated DNA probes for radiopharmaceutical applications, suggesting new therapeutic possibilities.
therapy), establishing the potential for using the information content of DNA to create multi-metalated radiopharmaceuticals. This programmable platform establishes a new paradigm for metalated molecular probe development with versatility for potential therapeutic, theranostic, and mass spectrometry-based applications, and potentially generalizable to other metal isotopes based on diagnostic or therapeutic requirements.
No takes yet. Share an insight, caveat, or question.
Wong et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: